B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Plx 4720

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Plx 4720, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

pazopanib
52 shared targets
raf
36 shared targets
defosbarasertib
34 shared targets
saracatinib
30 shared targets
foretinib
61 shared targets
motesanib
28 shared targets
vandetanib
42 shared targets
cediranib
36 shared targets
canertinib
41 shared targets
rebastinib
40 shared targets
Loading evidence profile...

This evidence profile for Plx 4720 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.